Does BOSUTINIB Cause Product prescribing issue? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Product prescribing issue have been filed in association with BOSUTINIB (BOSULIF). This represents 0.2% of all adverse event reports for BOSUTINIB.
14
Reports of Product prescribing issue with BOSUTINIB
0.2%
of all BOSUTINIB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Product prescribing issue From BOSUTINIB?
Of the 14 reports, 1 (7.1%) resulted in death, 2 (14.3%) required hospitalization.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOSUTINIB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does BOSUTINIB Cause?
Diarrhoea (1,820)
Nausea (886)
Fatigue (626)
Vomiting (469)
Death (465)
Rash (426)
Pleural effusion (398)
Neoplasm progression (376)
Dyspnoea (319)
Headache (283)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
Which BOSUTINIB Alternatives Have Lower Product prescribing issue Risk?
BOSUTINIB vs BOTOX
BOSUTINIB vs BOTOX COSMETIC
BOSUTINIB vs BOTULINUM TOXIN NOS
BOSUTINIB vs BOTULINUM TOXIN TYPE A
BOSUTINIB vs BREMELANOTIDE